129 related articles for article (PubMed ID: 24206567)
1. Potential gains and costs from increasing access to thrombolysis for acute ischemic stroke patients in New Zealand hospitals.
Te Ao B; Brown P; Fink J; Vivian M; Feigin V
Int J Stroke; 2015 Aug; 10(6):903-10. PubMed ID: 24206567
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of thrombolysis with recombinant tissue plasminogen activator for acute ischemic stroke assessed by a model based on UK NHS costs.
Sandercock P; Berge E; Dennis M; Forbes J; Hand P; Kwan J; Lewis S; Lindley R; Neilson A; Wardlaw J
Stroke; 2004 Jun; 35(6):1490-7. PubMed ID: 15105519
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of thrombolysis within 4.5 hours of acute ischemic stroke: experience from Australian stroke center.
Tan Tanny SP; Busija L; Liew D; Teo S; Davis SM; Yan B
Stroke; 2013 Aug; 44(8):2269-74. PubMed ID: 23780955
[TBL] [Abstract][Full Text] [Related]
4. Cost-Effectiveness of Endovascular Stroke Therapy: A Patient Subgroup Analysis From a US Healthcare Perspective.
Kunz WG; Hunink MG; Sommer WH; Beyer SE; Meinel FG; Dorn F; Wirth S; Reiser MF; Ertl-Wagner B; Thierfelder KM
Stroke; 2016 Nov; 47(11):2797-2804. PubMed ID: 27758942
[TBL] [Abstract][Full Text] [Related]
5. Acute Ischemic Stroke (AIS) patient management in French stroke units and impact estimation of thrombolysis on care pathways and associated costs.
Schmidt A; Heroum C; Caumette D; Le Lay K; Bénard S
Cerebrovasc Dis; 2015; 39(2):94-101. PubMed ID: 25660476
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of intravenous thrombolysis with alteplase within a 3-hour window after acute ischemic stroke.
Ehlers L; Andersen G; Clausen LB; Bech M; Kjølby M
Stroke; 2007 Jan; 38(1):85-9. PubMed ID: 17122430
[TBL] [Abstract][Full Text] [Related]
7. Are stroke units cost effective? Evidence from a New Zealand stroke incidence and population-based study.
Te Ao BJ; Brown PM; Feigin VL; Anderson CS
Int J Stroke; 2012 Dec; 7(8):623-30. PubMed ID: 22010968
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of thrombolysis within 4.5 hours of acute ischemic stroke in China.
Pan Y; Chen Q; Zhao X; Liao X; Wang C; Du W; Liu G; Liu L; Wang C; Wang Y; Wang Y;
PLoS One; 2014; 9(10):e110525. PubMed ID: 25329637
[TBL] [Abstract][Full Text] [Related]
9. Economic impact of using additional diagnostic tests to better select patients with stroke for intravenous thrombolysis in the United Kingdom.
Earnshaw SR; McDade C; Chapman AM; Jackson D; Schwamm L
Clin Ther; 2012 Jul; 34(7):1544-58. PubMed ID: 22695225
[TBL] [Abstract][Full Text] [Related]
10. Burden of stroke in Italy: an economic model highlights savings arising from reduced disability following thrombolysis.
Chiumente M; Gianino MM; Minniti D; Mattei TJ; Spass B; Kamal KM; Zimmerman DE; Muca A; Luda E
Int J Stroke; 2015 Aug; 10(6):849-55. PubMed ID: 25854294
[TBL] [Abstract][Full Text] [Related]
11. Cost-Effectiveness of Intra-Arterial Treatment as an Adjunct to Intravenous Tissue-Type Plasminogen Activator for Acute Ischemic Stroke.
Leppert MH; Campbell JD; Simpson JR; Burke JF
Stroke; 2015 Jul; 46(7):1870-6. PubMed ID: 26012639
[TBL] [Abstract][Full Text] [Related]
12. Real-life costs and effects of an implementation program to increase thrombolysis in stroke.
Dirks M; Baeten SA; Dippel DW; van Exel NJ; van Wijngaarden JD; Huijsman R; Koudstaal PJ; Niessen LW;
Neurology; 2012 Aug; 79(6):508-14. PubMed ID: 22786601
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness analysis of thrombolytic treatment for stroke.
Mar J; Begiristain JM; Arrazola A
Cerebrovasc Dis; 2005; 20(3):193-200. PubMed ID: 16088115
[TBL] [Abstract][Full Text] [Related]
14. Is the Cost-Effectiveness of Stroke Thrombolysis Affected by Proportion of Stroke Mimics?
Liberman AL; Choi HJ; French DD; Prabhakaran S
Stroke; 2019 Feb; 50(2):463-468. PubMed ID: 30572813
[TBL] [Abstract][Full Text] [Related]
15. Cost-Utility Analysis of Mechanical Thrombectomy Using Stent Retrievers in Acute Ischemic Stroke.
Ganesalingam J; Pizzo E; Morris S; Sunderland T; Ames D; Lobotesis K
Stroke; 2015 Sep; 46(9):2591-8. PubMed ID: 26251241
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of hub-and-spoke telestroke networks for the management of acute ischemic stroke from the hospitals' perspectives.
Switzer JA; Demaerschalk BM; Xie J; Fan L; Villa KF; Wu EQ
Circ Cardiovasc Qual Outcomes; 2013 Jan; 6(1):18-26. PubMed ID: 23212458
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of patient selection using penumbral-based MRI for intravenous thrombolysis.
Earnshaw SR; Jackson D; Farkouh R; Schwamm L
Stroke; 2009 May; 40(5):1710-20. PubMed ID: 19286581
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of tissue-type plasminogen activator in the 3- to 4.5-hour time window for acute ischemic stroke.
Tung CE; Win SS; Lansberg MG
Stroke; 2011 Aug; 42(8):2257-62. PubMed ID: 21719767
[TBL] [Abstract][Full Text] [Related]
19. Centralising and optimising decentralised stroke care systems: a simulation study on short-term costs and effects.
Lahr MM; van der Zee DJ; Luijckx GJ; Vroomen PC; Buskens E
BMC Med Res Methodol; 2017 Jan; 17(1):5. PubMed ID: 28073360
[TBL] [Abstract][Full Text] [Related]
20. A cost-utility analysis of mechanical thrombectomy as an adjunct to intravenous tissue-type plasminogen activator for acute large-vessel ischemic stroke.
Kim AS; Nguyen-Huynh M; Johnston SC
Stroke; 2011 Jul; 42(7):2013-8. PubMed ID: 21636817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
